{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T10:33:45Z","timestamp":1792492425960,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:00:00Z","timestamp":1714348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:00:00Z","timestamp":1714348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["SR-Tiget Core Grant TTACC0422TT"],"award-info":[{"award-number":["SR-Tiget Core Grant TTACC0422TT"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["UPGRADE"],"award-info":[{"award-number":["UPGRADE"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Lentiviral vectors (LV) are efficient vehicles for in vivo gene delivery to the liver. LV integration into the chromatin of target cells ensures their transmission upon proliferation, thus allowing potentially life-long gene therapy following a single administration, even to young individuals. The glycoprotein of the vesicular stomatitis virus (VSV.G) is widely used to pseudotype LV, as it confers broad tropism and high stability. The baculovirus-derived GP64 envelope protein has been proposed as an alternative for in vivo liver-directed gene therapy. Here, we perform a detailed comparison of VSV.G- and GP64-pseudotyped LV in vitro and in vivo. We report that VSV.G-LV transduced hepatocytes better than GP64-LV, however the latter showed improved transduction of liver sinusoidal endothelial cells (LSEC). Combining GP64-pseudotyping with the high surface content of the phagocytosis inhibitor CD47 further enhanced LSEC transduction. Coagulation factor VIII (FVIII), the gene mutated in hemophilia A, is naturally expressed by LSEC, thus we exploited GP64-LV to deliver a FVIII transgene under the control of the endogenous FVIII promoter and achieved therapeutic amounts of FVIII and correction of hemophilia A mice.<\/jats:p>","DOI":"10.1038\/s44321-024-00072-8","type":"journal-article","created":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T11:01:29Z","timestamp":1714388489000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["GP64-pseudotyped lentiviral vectors target liver endothelial cells and correct hemophilia A mice"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0363-678X","authenticated-orcid":false,"given":"Michela","family":"Milani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Canepari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Assanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Merlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Borroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0502-4442","authenticated-orcid":false,"given":"Francesco","family":"Starinieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6914-2854","authenticated-orcid":false,"given":"Mauro","family":"Biffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Fabiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4027-1094","authenticated-orcid":false,"given":"Desir\u00e8e","family":"Zambroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8541-2578","authenticated-orcid":false,"given":"Andrea","family":"Annoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7835-527X","authenticated-orcid":false,"given":"Luigi","family":"Naldini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Follenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9741-997X","authenticated-orcid":false,"given":"Alessio","family":"Cantore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,29]]},"reference":[{"key":"72_CR1","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1160\/TH05-08-0559","volume":"95","author":"WS Bril","year":"2006","unstructured":"Bril WS, van Helden PM, Hausl C, Zuurveld MG, Ahmad RU, Hollestelle MJ, Reitsma PH, Fijnvandraat K, van Lier RA, Schwarz HP et al (2006) Tolerance to factor VIII in a transgenic mouse expressing human factor VIII cDNA carrying an Arg(593) to Cys substitution. Thromb Haemost 95:341\u2013347","journal-title":"Thromb Haemost"},{"key":"72_CR2","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.virol.2006.10.025","volume":"360","author":"EM Campbell","year":"2007","unstructured":"Campbell EM, Perez O, Melar M, Hope TJ (2007) Labeling HIV-1 virions with two fluorescent proteins allows identification of virions that have productively entered the target cell. Virology 360:286\u2013293","journal-title":"Virology"},{"key":"72_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.774618","volume":"8","author":"A Cantore","year":"2022","unstructured":"Cantore A, Fraldi A, Meneghini V, Gritti A (2022) In vivo gene therapy to the liver and nervous system: promises and challenges. Front Med 8:774618","journal-title":"Front Med"},{"issue":"Suppl 3","key":"72_CR4","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/hae.14056","volume":"27","author":"A Cantore","year":"2021","unstructured":"Cantore A, Naldini L (2021) WFH State-of-the-art paper 2020: In vivo lentiviral vector gene therapy for haemophilia. Haemophilia 27(Suppl 3):122\u2013125","journal-title":"Haemophilia"},{"key":"72_CR5","doi-asserted-by":"publisher","first-page":"277ra228","DOI":"10.1126\/scitranslmed.aaa1405","volume":"7","author":"A Cantore","year":"2015","unstructured":"Cantore A, Ranzani M, Bartholomae CC, Volpin M, Valle PD, Sanvito F, Sergi LS, Gallina P, Benedicenti F, Bellinger D et al (2015) Liver-directed lentiviral gene therapy in a dog model of hemophilia B. Sci Transl Med 7:277ra228","journal-title":"Sci Transl Med"},{"key":"72_CR6","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.3324\/haematol.2019.239202","volume":"106","author":"R Fama","year":"2021","unstructured":"Fama R, Borroni E, Merlin S, Airoldi C, Pignani S, Cucci A, Cora D, Bruscaggin V, Scardellato S, Faletti S et al (2021) Deciphering the Ets-1\/2-mediated transcriptional regulation of F8 gene identifies a minimal F8 promoter for hemophilia A gene therapy. Haematologica 106:1624\u20131635","journal-title":"Haematologica"},{"key":"72_CR7","first-page":"935","volume":"118","author":"A Follenzi","year":"2008","unstructured":"Follenzi A, Benten D, Novikoff P, Faulkner L, Raut S, Gupta S (2008) Transplanted endothelial cells repopulate the liver endothelium and correct the phenotype of hemophilia A mice. J Clin Investig 118:935\u2013945","journal-title":"J Clin Investig"},{"key":"72_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.omtm.2018.10.006","volume":"12","author":"AM Frank","year":"2019","unstructured":"Frank AM, Buchholz CJ (2019) Surface-engineered lentiviral vectors for selective gene transfer into subtypes of lymphocytes. Mol Ther Methods Clin Dev 12:19\u201331","journal-title":"Mol Ther Methods Clin Dev"},{"key":"72_CR9","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.3390\/v12091016","volume":"12","author":"A Gutierrez-Guerrero","year":"2020","unstructured":"Gutierrez-Guerrero A, Cosset FL, Verhoeyen E (2020) Lentiviral vector pseudotypes: precious tools to improve gene modification of hematopoietic cells for research and gene therapy. Viruses 12:1016","journal-title":"Viruses"},{"key":"72_CR10","doi-asserted-by":"publisher","first-page":"3542","DOI":"10.1016\/j.ymthe.2022.10.004","volume":"30","author":"A Kapelanski-Lamoureux","year":"2022","unstructured":"Kapelanski-Lamoureux A, Chen Z, Gao ZH, Deng R, Lazaris A, Lebeaupin C, Giles L, Malhotra J, Yong J, Zou C et al (2022) Ectopic clotting factor VIII expression and misfolding in hepatocytes as a cause for hepatocellular carcinoma. Mol Ther 30:3542\u20133551","journal-title":"Mol Ther"},{"key":"72_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/mtm.2016.64","volume":"3","author":"AM Lange","year":"2016","unstructured":"Lange AM, Altynova ES, Nguyen GN, Sabatino DE (2016) Overexpression of factor VIII after AAV delivery is transiently associated with cellular stress in hemophilia A mice. Mol Ther Methods Clin Dev 3:16064","journal-title":"Mol Ther Methods Clin Dev"},{"key":"72_CR12","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1056\/NEJMoa2211075","volume":"388","author":"J Mahlangu","year":"2023","unstructured":"Mahlangu J, Kaczmarek R, von Drygalski A, Shapiro S, Chou SC, Ozelo MC, Kenet G, Peyvandi F, Wang M, Madan B et al (2023) Two-year outcomes of valoctocogene roxaparvovec therapy for hemophilia A. New Engl J Med 388:694\u2013705","journal-title":"New Engl J Med"},{"key":"72_CR28","doi-asserted-by":"crossref","unstructured":"Matrai J, Cantore A, Bartholomae CC, Annoni A, Wang W, Acosta-Sanchez A, Samara-Kuko E, De Waele L, Ma L, Genovese P et al (2011) Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigenspecific tolerance in mice with low genotoxic risk. Hepatology 53:1696\u20131707","DOI":"10.1002\/hep.24230"},{"key":"72_CR13","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1016\/j.ymthe.2017.04.029","volume":"25","author":"S Merlin","year":"2017","unstructured":"Merlin S, Cannizzo ES, Borroni E, Bruscaggin V, Schinco P, Tulalamba W, Chuah MK, Arruda VR, VandenDriessche T, Prat M et al (2017) A novel platform for immune tolerance induction in hemophilia A mice. Mol Ther 25:1815\u20131830","journal-title":"Mol Ther"},{"key":"72_CR14","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1182\/bloodadvances.2018027979","volume":"3","author":"S Merlin","year":"2019","unstructured":"Merlin S, Fama R, Borroni E, Zanolini D, Bruscaggin V, Zucchelli S, Follenzi A (2019) FVIII expression by its native promoter sustains long-term correction avoiding immune response in hemophilic mice. Blood Adv 3:825\u2013838","journal-title":"Blood Adv"},{"key":"72_CR15","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.15252\/emmm.201708148","volume":"9","author":"M Milani","year":"2017","unstructured":"Milani M, Annoni A, Bartolaccini S, Biffi M, Russo F, Di Tomaso T, Raimondi A, Lengler J, Holmes MC, Scheiflinger F et al (2017) Genome editing for scalable production of alloantigen-free lentiviral vectors for in vivo gene therapy. EMBO Mol Med 9:1558\u20131573","journal-title":"EMBO Mol Med"},{"key":"72_CR16","doi-asserted-by":"publisher","first-page":"eaav7325","DOI":"10.1126\/scitranslmed.aav7325","volume":"11","author":"M Milani","year":"2019","unstructured":"Milani M, Annoni A, Moalli F, Liu T, Cesana D, Calabria A, Bartolaccini S, Biffi M, Russo F, Visigalli I et al (2019) Phagocytosis-shielded lentiviral vectors improve liver gene therapy in nonhuman primates. Sci Transl Med 11:eaav7325","journal-title":"Sci Transl Med"},{"key":"72_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30102-3","volume":"13","author":"M Milani","year":"2022","unstructured":"Milani M, Canepari C, Liu T, Biffi M, Russo F, Plati T, Curto R, Patarroyo-White S, Drager D, Visigalli I et al (2022) Liver-directed lentiviral gene therapy corrects hemophilia A mice and achieves normal-range factor VIII activity in non-human primates. Nat Commun 13:2454","journal-title":"Nat Commun"},{"key":"72_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32576-7","volume":"13","author":"CT Nicolas","year":"2022","unstructured":"Nicolas CT, VanLith CJ, Hickey RD, Du Z, Hillin LG, Guthman RM, Cao WJ, Haugo B, Lillegard A, Roy D et al (2022) In vivo lentiviral vector gene therapy to cure hereditary tyrosinemia type 1 and prevent development of precancerous and cancerous lesions. Nat Commun 13:5012","journal-title":"Nat Commun"},{"key":"72_CR29","doi-asserted-by":"crossref","unstructured":"Olgasi C, Borsotti C, Merlin S, Bergmann T, Bittorf P, Adewoye AB, Wragg N, Patterson K, Calabria A, Benedicenti F et al (2021) Efficient and safe correction of hemophilia A by lentiviral vector-transduced BOECs in an implantable device. Mol Ther Methods Clin Dev 23:551\u2013566","DOI":"10.1016\/j.omtm.2021.10.015"},{"key":"72_CR19","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1056\/NEJMoa2211644","volume":"388","author":"SW Pipe","year":"2023","unstructured":"Pipe SW, Leebeek FWG, Recht M, Key NS, Castaman G, Miesbach W, Lattimore S, Peerlinck K, Van der Valk P, Coppens M et al (2023) Gene therapy with etranacogene dezaparvovec for hemophilia B. N. Engl J Med 388:706\u2013718","journal-title":"N. Engl J Med"},{"key":"72_CR20","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1182\/blood.2019002867","volume":"135","author":"J Poothong","year":"2020","unstructured":"Poothong J, Pottekat A, Siirin M, Campos AR, Paton AW, Paton JC, Lagunas-Acosta J, Chen Z, Swift M, Volkmann N et al (2020) Factor VIII exhibits chaperone-dependent and glucose-regulated reversible amyloid formation in the endoplasmic reticulum. Blood 135:1899\u20131911","journal-title":"Blood"},{"key":"72_CR21","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.2144\/02325st05","volume":"32","author":"W Rodgers","year":"2002","unstructured":"Rodgers W (2002) Making membranes green: construction and characterization of GFP-fusion proteins targeted to discrete plasma membrane domains. Biotechniques 32:1044\u20131051","journal-title":"Biotechniques"},{"key":"72_CR22","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/sj.gt.3302170","volume":"11","author":"CA Schauber","year":"2004","unstructured":"Schauber CA, Tuerk MJ, Pacheco CD, Escarpe PA, Veres G (2004) Lentiviral vectors pseudotyped with baculovirus gp64 efficiently transduce mouse cells in vivo and show tropism restriction against hematopoietic cell types in vitro. Gene Ther 11:266\u2013275","journal-title":"Gene Ther"},{"key":"72_CR23","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/sj.gt.3302399","volume":"12","author":"C Schauber-Plewa","year":"2005","unstructured":"Schauber-Plewa C, Simmons A, Tuerk MJ, Pacheco CD, Veres G (2005) Complement regulatory proteins are incorporated into lentiviral vectors and protect particles against complement inactivation. Gene Ther 12:238\u2013245","journal-title":"Gene Ther"},{"key":"72_CR24","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/ni1527","volume":"8","author":"K Takenaka","year":"2007","unstructured":"Takenaka K, Prasolava TK, Wang JC, Mortin-Toth SM, Khalouei S, Gan OI, Dick JE, Danska JS (2007) Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. Nat Immunol 8:1313\u20131323","journal-title":"Nat Immunol"},{"key":"72_CR25","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1089\/hum.2019.140","volume":"30","author":"N Zabaleta","year":"2019","unstructured":"Zabaleta N, Hommel M, Salas D, Gonzalez-Aseguinolaza G (2019) Genetic-based approaches to inherited metabolic liver diseases. Hum Gene Ther 30:1190\u20131203","journal-title":"Hum Gene Ther"},{"key":"72_CR26","doi-asserted-by":"publisher","first-page":"881","DOI":"10.3324\/haematol.2014.123117","volume":"100","author":"D Zanolini","year":"2015","unstructured":"Zanolini D, Merlin S, Feola M, Ranaldo G, Amoruso A, Gaidano G, Zaffaroni M, Ferrero A, Brunelleschi S, Valente G et al (2015) Extrahepatic sources of factor VIII potentially contribute to the coagulation cascade correcting the bleeding phenotype of mice with hemophilia A. Haematologica 100:881\u2013892","journal-title":"Haematologica"},{"key":"72_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/mtm.2016.63","volume":"3","author":"I Zolotukhin","year":"2016","unstructured":"Zolotukhin I, Markusic DM, Palaschak B, Hoffman BE, Srikanthan MA, Herzog RW (2016) Potential for cellular stress response to hepatic factor VIII expression from AAV vector. Mol Ther Methods Clin Dev 3:16063","journal-title":"Mol Ther Methods Clin Dev"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-024-00072-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-024-00072-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-024-00072-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T06:16:42Z","timestamp":1785737802000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-024-00072-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,29]]},"references-count":29,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6,14]]}},"alternative-id":["72"],"URL":"https:\/\/doi.org\/10.1038\/s44321-024-00072-8","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,29]]},"assertion":[{"value":"6 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"LN, AC, AA, MM, AFo, and SM are inventors on patent applications submitted by Fondazione Telethon, San Raffaele Scientific Institute, Bioverativ\/Sanofi or University of Piemonte Orientale on LV technology related to the work presented in this manuscript. Fondazione Telethon and San Raffaele Scientific Institute through SR-Tiget, have established a research collaboration on liver-directed lentiviral gene therapy of hemophilia with GeneSpire. Luigi Naldini is a member of the journal\u2019s editorial board. This has no bearing on the editorial consideration of this article for publication. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}],"article-number":"11"}}